Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Edesa Biotech Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
VC
Velan Capital Investment Management LP
13D · 10.0%
|
827.5K | 8.58% | Unchanged | 2025 | 4.1% | |
|
Shares held by quarter
Peak holding827.5K (Q1'26)
Change over 8 quarters+827.5K
Share of the company8.580%
Disclosed stake13D · 10.0%
|
||||||
|
RC
Rubric Capital Management LP
|
669.5K | 6.94% | −18.0K (−2.6%) | 2025 | 0.1% | |
|
Shares held by quarter
Peak holding687.5K (Q1'25)
Change over 8 quarters+669.5K
Share of the company6.940%
|
||||||
28 more super investors behind a free account
See every manager holding Edesa Biotech Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VE
Vanguard Index Funds
|
$573K | 70.4K | 0.73% | 0.00% | June 30, 2026 |
|
FE
Fidelity Concord Street Trust
|
$167K | 35.2K | 0.37% | 0.00% | August 31, 2026 |
4 more funds behind a free account
See every fund holding Edesa Biotech Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
PN
Pardeep Nijhawan
5%+ holder
13D · 16.3%
|
2.6M | 27.11% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
VC
Velan Capital Management LLC
5%+ holder
13D · 10.0%
|
1.4M | 14.07% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
15 more holders behind a free account
See every insider and 5%+ holder of Edesa Biotech Inc.
Sign up freeLoading...